Frazier Healthcare Partners takes majority stake in bioengineering firm Atum
The Newark, California-based company combines machine learning, gene synthesis and cell line development to help biopharma companies bring new therapies to the clinic.
The Newark, California-based company combines machine learning, gene synthesis and cell line development to help biopharma companies bring new therapies to the clinic.